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 ABSTRACT 
 
Objective: The intended research work aims to evaluate the effect of 12 week Ujjayi 
pranayama on Hypothyroidism in adults and to compare the changes in BMI and Thyroid 
Function Test [Tri- iodothyronine T3,Thyroxine T4, Thyroid-stimulating hormone] 
before and after Psychic breathing technique .Many studies reported that the practice of 
yoga, especially pranayama‘ influences BMI. The current study was conducted to 
determine the effect of practicing Ujjayi Pranayama on Hypothyroidism in Adults, 
followed by monitoring BMI and Thyroid Function Test. 
  
Study Design: The current research work employed A Randomized Controlled Trail. 
 
 
Method: 
Potential subject will be screened and eligible patients will be recruited for the study.A 
minimum of 60 participants in Study group and minimum of 60 participants in Control 
group belonging within the age group of 18-55 participate in the study. After obtaining 
informed consent both the group will be subjected to general measures like BMI, Thyroid 
Function Test before and after the study. The study Group will be subjected to Ujjayi 
Pranayama for 15 minutes twice a day for 6 days a week for 12 weeks.   
 
Result: 
Results of the pre and post measurements on T3, T4, TSH, Body weight and BMI  among 
Ujjai pranayama along with standard drug group for a period of 90 days shows that Body 
weight was reduced and T3 got raised statistically significant after the yoga intervention  
 
                                                                   ix 
where as T4 doesn’t show’s any statistical significance after the yoga intervention. Even 
though in yoga intervention group T4 doesn’t show statistical significance its mean value 
raised to a marked level from 8.05 to 8.54 mg/dl .This shows that ujjai pranayama is 
influencing the T4 secretion.  TSH level reduced significantly after the practice of ujjai 
pranayama for a period of 90 days.  
Conclusion:  
This study showed that 90 days of Ujjayi Pranayama reduced Body mass index and 
Thyroid Stimulating Hormone (TSH), Triiodothyronine (T3 ) and no significant 
differences in Thyroxine (T4)  hypothyroid patients. This revealed that yoga practice has 
significant role in improvement in the weight reduction. Further research need in this 
field with a larger sample size and duration is warranted to reveal accurate changes in this 
field. 
 
Keywords: 
 
 
 
Hypothyroidism, Ujjayi Pranayama, Basal Metabolic Index, Thyroid Stimulating 
Hormone, 
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                                        1.0 INTRODUCTION 
Hypothyroidism is defined as a clinical state resulting from insufficient secretion of the 
thyroid hormone from thyroid gland due to some of the structural or functional 
impairment of the thyroid hormone production(1). The thyroid gland is located inside the 
neck, just below adam’s apple and It produces two thyroid hormones, triodothyronine 
(T3) and thyroxine (T4), which regulate the body metabolic rate(2). Hypothyroidism 
affects all the organ systems and main  clinical findings are fatigue, weakness, dryness, 
coarseness of the skin, cold intolerance, swelling of extremities, lack of concentration, 
memory, constipation and weight gain, menorrhagia, paresthesia, hearing disorder,diffuse 
alopecia, bradycardia, delayed relaxation of tendon reflexes, carpel tunnel syndrome, 
serous cavitary effusion(3).There are intricate feedback mechanisms between the thyroid 
and anterior pituitary, hypothyroidism is classified as primary when thyroxin (T4) and 
triiodothyronine (T3) levels are low but levels of thyroid stimulating hormone (TSH) 
secreted by anterior pituitary high(4). It is classified as secondary when TSH is low and 
T4 and T3 levels are high and presents a large epidemiological burden in India(5). 
Imbalance in production of thyroid stimulating hormone ( TSH) or hypothalamus, which 
regulates the pituitary gland via thyrotropin releasing hormone(TRH)(6). Thyroid 
disorders can range from a small, harmless goiter (enlarged gland) that needs no 
treatment to life threatening cancer(7). The most common thyroid problems involve 
abnormal production leads to hypothyroidism, as the result of subtle and non speciﬁc 
clinical symptoms and signs, the condition often go undiagnosed and are not adequately 
treated when it is detected(8). There is heterogeneity in the diagnostic and treatment 
approaches to hypothyroidism(9). As a result of the physiological changes in thyroid 
hormones with age and illness, it is important to tailor the diagnosis and management of 
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this condition in speciﬁc populations including pregnant women, infants, children, 
geriatric patients, and those with comorbid conditions(10). 
1.1 YOGA 
Yoga is an art and scince of healthy living. The word ‘Yoga’ is derived from the Sanskrit 
root ‘Yuj’, meaning ‘to join’ or ‘to yoke’ or ‘to unite’. As per Yogic scriptures the 
practice of Yoga leads to the union of individual consciousness with that of the Universal 
Consciousness, indicating a perfect harmony between the mind and body, Man & 
Nature(11). The aim of Yoga is Self-realization, to overcome all kinds of sufferings 
leading to 'the state of liberation' (Moksha) or ‘freedom’ (Kaivalya). Living with freedom 
in all walks of life, health and harmony shall be the main objectives of Yoga practice. 
"Yoga” also refers to an inner science comprising of a variety of methods through which 
human beings can realize this union and achieve mastery over their destiny (12). Yoga, 
being widely considered as an ‘immortal cultural outcome’ of Indus Saraswati Valley 
civilization dating back to 2700 B.C., has proved itself catering to both material and 
spiritual upliftment of humanity. Basic humane values are the very identity of Yoga 
Sadhana. Yoga is also commonly understood as a therapy or exercise system for health 
and fitness. While physical and mental health is natural consequences of yoga, the goal of 
yoga is more far-reaching (13). "Yoga is about harmonizing oneself with the universe. It 
is the technology of aligning individual geometry with the cosmic, to achieve the highest 
level of perception and harmony.”  
Patanjali’s definition of yoga 
The great sage Patanjali, in the system of Raja Yoga, gave one of the best definitions of 
yoga. He said, ‘Yoga is the blocking (nirodha) of mental modifications (chitta vritti) so 
that the seer (drashta) re-identifies with the (higher) Self. Patanjali’s system has come to 
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be the epitome of Classical Yoga Philosophy and is one of the 7 major philosophies of 
India(14). Patanjali gives a wide range of techniques that slowly harmonizes the mind 
and gradually induces more subtle perception. However, the main path of Patanjali is 
contained within eight fundamental stages. The first five are: 
 Yama (social code) 
 Niyama (personal code) 
 Asana (sitting pose) 
 Pranayama (control of prana) 
 Pratyahara (sense withdrawal) 
 
These first five stages are the esoteric/bahiranga (external) practices of yoga. They 
progressively prepare the body-mind for the last stages: 
 Dharana (concentration) 
 Dhyana (meditation) 
 Samadhi (superconsciousness) 
These last three stages are the esoteric or antaranga (internal) practices of yoga. The first 
five stages negate consciousness, whilst the last three stages expand consciousness. 
1.2 PRANAYAMA 
Practicing Pranayama helps in controlling the breath. The terminology was coined  from 
the two root words namely ‘prana’ meaning ‗vital energy‘ and ayama’ meaning 
extension/breath‘. The practice of pranayama cannot be considered as a simplified 
breathing exercise; rather it aims at channeling the flow of excess oxygen into the lungs, 
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thereby, transporting it to all the systemic organs of the body(15).In the pranayama 
practices there are four important aspects of breathing which are utilized. These are: 
 Pooraka or inhalation 
 Rechaka or exhalation 
 Antarkunbhaka or internal breath retention 
 Bahirkumbhaka or external breath retention. 
As Yoga was globally regarded as The ancient Indian science‘ which comprised of 
practices, which involved specific postures (asanas) and regulated breathing 
(Pranayama). There were reports suggesting different types of pranayama exhibiting 
different autonomic and cardiac responses among healthy humans(16). Many reports 
claimed that the practice of pranayama aids in eliminating the toxins away from the body 
and helps in maintaining a good health. There are different variations/types of pranayama 
such as 
 AnulomVilom Pranayama 
 Bahya Pranayama 
 Bhastrika Pranayama 
 Bhramari Pranayama 
 Digra Pranayama 
 Kapalbhati Pranayama 
 NadiSodhana Pranayama 
 Shitali Pranayama 
 Udgit Pranayama 
 Ujjayi Pranayama 
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1.3 GHERANDA SAMHITA  
Gheranda Samhita  is a Sanskrit text of Yoga in Hinduism and it is one of the three 
classic texts of hatha yoga . The Gheranda Samhita calls itself a book on ghatastha yoga, 
which literally means "vessel yoga", wherein the body and mind are depicted as vessels 
that carry and serve the soul (atman, purusha). The text teaches a seven limbed. Gheranda 
Samhita is a step by step detailed manual of yoga taught by sage Gheranda to student 
Chanda.[14] Unlike other hatha yoga texts, the Gheranda Samhita speaks of a sevenfold 
Yoga and Pranayama is one of the important practice explained in this text 
1.4 UJJAYI  PRANAYAMA – The Psychic Breath 
Ujjayi Prananaya or the psychic breath soothes the mind and induces a meditative 
state.  Ujjayi means to ‘lift up’. In Ujjayi pranayama, the chest is slightly lifted up as if 
the inhalation is done from the throat. Ujjayipranayama is mentioned in the yoga 
text Hatha Yoga Pradeepika and in the Gheranda Samhita. The Procedure of Ujjayi 
pranayama or Psychic breathing according to Gherenda Samhita: 
 Sit in a comfortable meditative pose Siddhasana or Swastikasana, or Vajrasana. 
 Contract the glottis, so that the passage of  the throat is partially closed 
 Roll the tongue up and let the lower side of the tongue touch the upper palate 
 Breath in slowly through the throat, amking a slight hissing snoring sound. 
 When the inhalation is complete, swallow the breath and perform Jalandhara 
Bandha( the chin lock) 
 Retain the breath inside for asa long as you are comfortable 
 Reseale the chin lock (Jalandhara Bandha) and exhale through both the nostrils. 
 This is one round od Ujjayi Pranayama. Do as many rounds as comfortable for 15 
Benefits of Ujjayi Pranayama[8] 
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The current study focuses on Ujjayi pranayama on adult hypothyroidism  and its impact 
on BMI and Thyroid Function Test. Thus Ujjaiyi is considered as supportive and 
complimentary therapy in conjunction with medical  therapy for the treatment of 
hypothyroid disorder. Though Ujjayi pranayama is being widely used as a yoga therapy 
for various diseases in Yogic system of medicine, to the best of our knowledge, there is 
lack of scientific evidence in reporting the effect of Ujjayi pranayama  on adult 
Hypothyroidism. Hence the rationale is to observe the changes in BMI and Thyroid 
profile in adult Hypothyroidism. 
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  2.0 AIMS AND OBJECTIVES  
2.1 AIM 
The aim of this study was to asses the effect of Ujjayi pranayama on adult 
Hypothyroidism 
2.2 OBJECTIVES OF THE STUDY 
2.2.1 Primary Objective:  
To evaluate the effect of 12 week Ujjayi Pranayama on Hypothyroidism adult 
patients (in- and out-patients) of Government Yoga and Naturopathy Hospital, 
Arumbakkam, Chennai. 
 2.2.2 Secondary Objective: To compare the changes in BMI and Thyroid Function  
 Test – [ Tri-iodothyronine T4, Throxine T4,Thyroid stimulating hormone]  befor 
and after the  Ujjayi Pranayama (Psychic breathing technique). 
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     3.0 REVIEW OF LITERATURE 
3.1 HYPOTHYROIDISM 
Hypothyroidism is defined as a clinical state resulting from insufficient secretion of the 
thyroid hormone from thyroid gland due to some of the structural or functional 
impairment of the thyroid hormone production(14). The thyroid gland is located inside 
the neck, just below adam’s apple. It produces two thyroid hormones, triiodothyronine 
(T3) and thyroxine (T4), which regulate the body metabolic rate(17). 
 
Figure 1 : Anatomy of thyroid gland 
There are intricate feedback mechanisms between the thyroid and anterior pituitary, 
hypothyroidism is classified as primary when thyroxin (T4) and triiodothyronine (T3) 
levels are low but levels of thyroid stimulating hormone (TSH) secreted by anterior 
pituitary high. It is classified as secondary when TSH is low and T4 and T3 levels are 
high(18). 
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3.2 PREVALENCE OF HYPOTHYROIDISM 
The prevalence of hypothyroidism in developed countries is about 4% - 5%, when 
compared to the western countries (UK,2%;USA,4.6%),a higher prevalence of 
hypothyroidism is reported in India is around 10.95% . One in ten adults is said to have 
hypothyroidism in India(19). In fact an estimated 108 million people in India suffer from 
endocrine and metabolic disorders. Several of these diseases are caused by environmental 
factors .therefore , their prevalence is several fold higher. Thyroid disorders are the most 
common among all the endocrine diseases in India (20). 
 
                                  Figure 1 : Anatomy of thyroid gland 
 
Hypothyroidism presents a large epidemiological burden in India. . Imbalance in 
production of thyroid stimulating hormone (TSH) ,or hypothalamus, which regulates the 
pituitary gland via thyrotropin releasing hormone(TRH). Thyroid disorders can range 
from a small, harmless goiter (enlarged gland) that needs no treatment to life threatening 
cancer. The most common thyroid problems involve abnormal production leads to 
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hypothyroidism(21). As a result of subtle and non speciﬁc clinical symptoms and signs, 
the condition often go undiagnosed and are not adequately treated when it is detected. 
There is heterogeneity in the diagnostic and treatment approaches to hypothyroidism. As 
a result of the physiological changes in thyroid hormones with age and illness, it is 
important to tailor the diagnosis and management of this condition in speciﬁc populations 
including women, infants, children, geriatric patients, and those with comorbid 
conditions(22). 
3.3THE THYROID GLAND  
 Thyroid gland is an endocrine gland in the neck, consisting of two lobes connected by 
an isthmus and is found at the front of the neck, below the Adam's apple. The thyroid 
gland secretes three hormones, namely the two thyroid 
hormones (thyroxine/T4 and triiodothyronine/T3), and calcitonin(23). The thyroid 
hormones primarily influence the metabolic rate and protein synthesis. Calcitonin  plays 
an important role in calcium homeostasis. Hormonal output from the thyroid is regulated 
by thyroid-stimulating hormone (TSH) secreted from the anterior pituitary gland, which 
itself is regulated by thyrotropin-releasing hormone (TRH) produced by 
the hypothalamus(24).  
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                                          Figure 3: Flow chart of HPT axis 
Thyroid is affected by many diseases. Hypothyroidism is a state of insufficient thyroid 
hormone production. the most common cause is iodine deficiency. Thyroid hormones are 
important for development, and hypothyroidism secondary to iodine deficiency remains 
the leading cause of preventable intellectual disability(25). In iodine-sufficient regions, 
the most common cause of hypothyroidism is Hashimoto's thyroiditis, also an 
autoimmune disorder. In addition, the thyroid gland may also develop several types 
of nodules and cancer. 
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3.3.1 BLOOD SUPPLY OF THYROID GLAND 
The thyroid is supplied with arterial blood from the superior thyroid artery, a branch of 
the external carotid artery, and the inferior thyroid artery, a branch of the thyro cervical 
trunk, and sometimes by an anatomical variant the thyroid in an artery, which has a 
variable origin(26). The superior thyroid artery splits into anterior and posterior branches 
supplying the thyroid, and the inferior thyroid artery splits into superior and inferior 
branches(27). The superior and inferior thyroid arteries join together behind the outer part 
of the thyroid lobes(28). The venous blood is drained via superior and middle thyroid 
veins, which drain to the internal jugular vein, and via the inferior thyroid veins(29). The 
inferior thyroid veins originate in a network of veins and drain into the left and 
right brachiocephalic veins(30). Both arteries and veins form a plexus between the two 
layers of the capsule of the thyroid gland.  
3.3.2 THE LYMPH SUPPLY 
Lymphatic drainage frequently passes the pre laryngeal lymph nodes (located just above 
the isthmus), and the pre tracheal and para tracheal lymph nodes(31).  
3.3.3THE NERVOUS SUPPLY 
The gland receives sympathetic nerve supply from the superior, middle and inferior 
cervical ganglion of the sympathetic trunk. The gland receives parasympathetic 
nerve supply from the superior laryngeal nerve and the recurrent laryngeal nerve(32).  
3.3.4 VARIATION: 
Sometimes there is a third lobe present called the pyramidal lobe. This lobe often 
stretches up the hyoid bone from the thyroid isthmus and may be one to several divided 
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lobes and it present in 18.3% to 44.6%. It mainly arises from the left side and 
occasionally separated. The pyramidal lobe is also known as Lalouette's pyramid(33). A 
small horn at the back of the thyroid lobes, usually close to the recurrent laryngeal nerve 
and the inferior thyroid artery, is called Zuckerkandl's tubercle(34). Other variants 
include a levator muscle of thyroid gland, connecting the isthmus to the body of the hyoid 
bone and the presence of the small thyroid ima artery(35).  
3.3.5 MICROANATOMY 
Section of thyroid gland under the microscope: 
1. Follicles 
2. Follicular cells 
3. Para follicular cells 
 
                    Figure 4 : Microscopic representation of thyroid follicles 
FOLLICLES 
Thyroid follicles are small spherical groupings of cells 0.02–0.9mm in diameter that play 
the main role in thyroid function(36). They consist of a rim that has a rich blood supply, 
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nerve and lymphatic presence, that surrounds a core of colloid that consists mostly of 
thyroid hormone precursor proteins called thyroglobulin, an iodinated glycoprotein(31).  
 
FOLLICULAR CELLS 
The core of a follicle is surrounded by a single layer of follicular cells. When stimulated 
by thyroid stimulating hormone (TSH), these secrete the thyroid hormones T3 and T4. 
They do this by transporting and metabolising the thyroglobulin contained in the 
colloid(37). Follicular cells vary in shape from flat to cuboid to columnar, depending on 
how active they are.  
 
PARA FOLLICULAR CELLS 
Scattered among follicular cells and in spaces between the spherical follicles are another 
type of thyroid cell, parafollicular cells secrete calcitonin and so are also called C 
cells(4).  
3.3.6 THYROID HORMONES 
The primary function of the thyroid is the production of iodine containing thyroid 
hormones such as 
  Tri -iodothyronine (T3)   
  Thyroxine (T4)  
 The Peptide hormone  Calcitonin 
 The thyroid hormones are created from iodine and tyrosine. T3 is so named because it 
contains three atoms of iodine per molecule and T4 contains four atoms of iodine per 
molecule. The thyroid hormones have a wide range of effects on the human body.  
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                                         Figure 5 : Hypothalamic pituitary thyroid axis 
METABOLISM 
The thyroid hormones increase the basal metabolic rate and have effects on almost all 
body tissues. Appetite, the absorption of substances, and gut motility are all influenced by 
thyroid hormones(38). They increase the absorption in the gut, generation, uptake by 
cells, and breakdown of glucose. They stimulate the breakdown of fats, and increase the 
number of free fatty acids. Despite increasing free fatty acids, thyroid hormones 
decrease cholesterol levels by increasing the rate of secretion of cholesterol in bile. 
16 
 
 
          Figure 6 : Feedback mechanism of thyroid system 
CARDIOVASCULAR:  
Thyroid hormones increase the rate and strength of the heartbeat. They increase the rate 
of breathing, intake and consumption of oxygen, and increase the activity 
of mitochondria(39). Combined, these factors increase blood flow and the body's 
temperature.  
DEVELOPMENT:  
Thyroid hormones are important for normal development. They increase the growth rate 
of young people, and cells of the developing brain .Thyroid hormones play a particularly 
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crucial role in brain maturation during fetal development and first few years of postnatal 
life(1). 
SEXUAL FUNCTION:  
Thyroid hormones also play a role in maintaining normal sexual function, sleep, and 
thought patterns. Increased levels are associated with increased speed of thought 
generation but decreased focus. Sexual function, including libido and the maintenance of 
a normal menstrual cycle, are influenced by thyroid hormones(28). After secretion, only a 
very small proportion of the thyroid hormones travel freely in the blood. Most are bound 
to thyroxine binding globulin (about70%), transthyretin (10%), and albumin (15%). Only 
the 0.03% of T4 and 0.3% of T3 traveling freely have hormonal activity(40). In addition, 
up to 85% of the T3 in blood is produced following conversion from T4 by iodothyronine 
deiodinases in organs around the body. Thyroid hormones act by crossing the cell 
membrane and binding to intracellular nuclear thyroid hormone receptors TR-α1,TR-
α2,TR-β1 and TR-β2, which ind with hormone response elements and transcription 
factors to modulate DNA transcription.In addition to these actions on DNA, the thyroid 
hormones also act within the cell membrane or within cytoplasm via reactions 
with enzymes, including calcium ATPase, adenylyl cyclase, and glucose transporters(24).  
3.3.7 HORMONE PRODUCTION  
Iodine is essential for the production of the thyroid hormones. Iodine (I0) travels in the 
blood as iodide (I−), which is taken up into the follicular cells by a sodium-iodide 
symporter. This is an ion channel on the cell membrane which in the same action 
transports two sodium ions and an iodide ion into the cell(14). Iodide then travels from 
within the cell into the follicular space, through the action of pendrin, an iodide-
chloride antiporter. In the follicular space, the iodide is then oxidized to iodine. This 
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makes it more reactive, and the iodine is attached to the active tyrosine units in 
thyroglobulin by the enzyme thyroid peroxidase(41–43). This forms the precursors of 
thyroid hormones monoiodotyrosine (MIT), and diiodotyrosine (DIT).  
 
                  Figure 7 : Schematic representation of thyroid hormone secretion 
When the follicular cells are stimulated by thyroid-stimulating hormone, the follicular 
cells reabsorb thyroglobulin from the follicular space. The iodinated tyrosines are 
cleaved, forming the thyroid hormones T4, T3, DIT, MIT, and traces of reverse 
triiodothyronine(14). T3and T4 are released into the blood. The hormones secreted from 
the gland are about 80–90% T4 and about 10–20% T3. Deiodinase enzymes in peripheral 
tissues remove the iodine from MIT and DIT and convert T4 to T3 and RT3. This is a 
major source of both RT3 (95%) and T3 (87%) in peripheral tissues.The signs and 
symptoms of hypothyroidism vary, depending on the severity of the hormone deficiency. 
Problems tend to develop slowly, often over a number of years. At first, you may barely 
notice the symptoms of hypothyroidism, such as fatigue and weight gain. Or you may 
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simply attribute them to getting older(42). But as your metabolism continues to slow, you 
may develop more-obvious problems. 
3.3.8  ETIOLOGY  
Hypothyroidism results when the thyroid gland fails to produce enough hormones., the 
balance of chemical reactions in the body can be upset and  have an enormous impact on 
health, affecting all aspects of metabolism. These hormones also influence the control of 
vital functions, such as body temperature and heart rate(44). There can be a number of 
causes, including autoimmune disease, hyperthyroidism treatments, radiation therapy, 
thyroid surgery and certain medications. 
Hypothyroidism may be due to a number of factors, including: 
AUTOIMMUNE DISEASE:  
The most common cause of hypothyroidism is an autoimmune disorder known as 
Hashimoto's thyroiditis. Autoimmune disorders occur when your immune system 
produces antibodies that attack its own tissues. Sometimes this process involves your 
thyroid gland. 
OVER RESPONSE TO HYPERTHYROIDISM TREATMENT: 
 People who produce too much thyroid hormone (hyperthyroidism) are often treated with 
radioactive iodine or anti-thyroid medications. The goal of these treatments is to get 
thyroid function back to normal. But sometimes, correcting hyperthyroidism can end up 
lowering thyroid hormone production too much, resulting in permanent hypothyroidism. 
THYROID SURGERY:  
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Removing all or a large portion of your thyroid gland can diminish or halt hormone 
production. In that case, you'll need to take thyroid hormone for life. 
RADIO THERAPY:  
Radiation used to treat cancers of the head and neck can affect your thyroid gland and 
may lead to hypothyroidism. 
 
 
MEDICATION:  
A number of medications can contribute to hypothyroidism. One such medication is 
lithium, which is used to treat certain psychiatric disorders. If you're taking medication, 
ask your doctor about its effect on your thyroid gland. 
CONGENITAL DISEASE:  
Some babies are born with a defective thyroid gland or no thyroid gland. In most cases, 
the thyroid gland didn't develop normally for unknown reasons, but some children have 
an inherited form of the disorder. Often, infants with congenital hypothyroidism appear 
normal at birth. That's one reason why most states now require new-born thyroid 
screening. 
PITUITARY DISORDER:  
A relatively rare cause of hypothyroidism is the failure of the pituitary gland to produce 
enough thyroid-stimulating hormone (TSH) usually because of a benign tumor of the 
pituitary gland. 
PREGNANCY: 
Some women develop hypothyroidism during or after pregnancy (postpartum 
hypothyroidism), often because they produce antibodies to their own thyroid gland. Left 
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untreated, hypothyroidism increases the risk of miscarriage, premature delivery and 
preeclampsia, a condition that causes a significant rise in a woman's blood pressure 
during the last three months of pregnancy. It can also seriously affect the developing 
fetus. 
 IODINE DEFICIENCY: 
 The trace mineral iodine is mainly found primarily in seafood, seaweed, plants grown in 
iodine-rich soil and iodized salt which  is essential for the production of thyroid 
hormones. Too little iodine can lead to hypothyroidism, and too much iodine can worsen 
hypothyroidism in people who already have the condition. In some parts of the world, 
iodine deficiency is common, but the addition of iodine to table salt has virtually 
eliminated this problem in the United States.  
Complications 
Untreated hypothyroidism can lead to a number of health problems: 
 Goiter. Constant stimulation of your thyroid to release more hormones may cause 
the gland to become larger — a condition known as a goiter. Although generally not 
uncomfortable, a large goiter can affect your appearance and may interfere with 
swallowing or breathing. 
 Heart problems. Hypothyroidism may also be associated with an increased risk 
of heart disease and heart failure, primarily because high levels of low-density 
lipoprotein (LDL) cholesterol the "bad" cholesterol that can occur in people with an 
underactive thyroid. 
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 Mental health issues. Depression may occur early in hypothyroidism and may 
become more severe over time. Hypothyroidism can also cause slowed mental 
functioning. 
 Peripheral neuropathy. Long-term uncontrolled hypothyroidism can cause 
damage to your peripheral nerves. These are the nerves that carry information from 
your brain and spinal cord to the rest of your body. for example, your arms and legs. 
Peripheral neuropathy may cause pain, numbness and tingling in affected areas. 
 Myxedema. This rare, life-threatening condition is the result of long-term, 
undiagnosed hypothyroidism. Its signs and symptoms include intense cold intolerance 
and drowsiness followed by profound lethargy and unconsciousness. A myxedema 
coma may be triggered by sedatives, infection or other stress on your body. If you 
have signs or symptoms of myxedema, you need immediate emergency medical 
treatment. 
 Infertility. Low levels of thyroid hormone can interfere with ovulation, which 
impairs fertility. In addition, some of the causes of hypothyroidism such as 
autoimmune disorder that can also impair fertility. 
 Birth defects. Babies born to women with untreated thyroid disease may have a 
higher risk of birth defects compared to babies born to healthy mothers. These 
children are also more prone to serious intellectual and developmental problems. 
Infants with untreated hypothyroidism present at birth are at risk of serious problems 
with both physical and mental development(45). But if this condition is diagnosed 
within the first few months of life, the chances of normal development are excellent. 
3.3.9 CLINICAL FEATURES 
Hypothyroidism signs and symptoms may include: 
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 Fatigue 
 Increased sensitivity to cold 
 Constipation 
 Dry skin 
 Weight gain 
 Puffy face 
 Hoarseness 
 Muscle weakness 
 Elevated blood cholesterol level 
 Muscle aches, tenderness and stiffness 
 Pain, stiffness or swelling in your joints 
 Heavier than normal or irregular menstrual periods 
 Thinning hair 
 Slowed heart rate 
 Depression 
 Impaired memory 
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                        Figure 9: Symptoms of hypothyroidism 
 
3.3.10 PATHOPHYSIOLOGY OF HYPOTHYROIDISM: 
The thyroid is a butterfly-shaped gland located in the front of the neck just above the 
trachea. It weighs approximately 15 to 20 grams in the adult human. The thyroid 
produces and releases into the circulation at least two potent hormones, thyroxine (T4) 
and triiodothyronine (T3), which influence basal metabolic processes and/or enhance 
oxygen consumption in nearly all body tissues(20). Thyroid hormones also influence 
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linear growth, brain function including intelligence and memory, neural development, 
dentition, and bone development(1).The thyroid gland produces T4 and T3 utilizing iodide 
obtained either from dietary sources or from the metabolism of thyroid hormones and 
other iodinated compounds. About 100 µg of iodide is required on a daily basis to 
generate sufficient quantities of thyroid hormone. Dietary ingestion of iodide in the 
United States ranges between 200 and 500 µg/day and varies geographically; ingestion is 
higher in the western part of the United States than in the eastern states. The specialized 
thyroid epithelial cells of the thyroid gland are equipped with a Na/I symporter that helps 
concentrate iodide 30 to 40 times the level in plasma to ensure adequate amounts for the 
synthesis of thyroid hormone. The iodide trapped by the thyroid gland is subsequently 
oxidized to iodine by the enzyme thyroid peroxidase(38). The iodine then undergoes a 
series of organic reactions within the thyroid gland to produce tetraiodothyronine or 
thyroxine (T4) and triiodothyronine (T3)(46). T3 is also produced in other tissues such as 
the pituitary, liver, and kidney by the removal of an iodine molecule from T4. T4 is 
considered to be more of a pro-hormone, while T3 is the most potent thyroid hormone 
produced. T4 and T3 are both stored in the thyroglobulin protein of the thyroid gland and 
released into the circulation through the action of pituitary derived thyrotropin (thyroid 
stimulating hormone or TSH)(47). A normal individual produces from the thyroid gland 
approximately 90 to 100 µg of T4 and 30 to 35 µg of T3 on a daily basis. An estimated 80 
percent of the T3 produced daily in humans is derived from peripheral metabolism (5′-
monodeiodination) of T4, with only about 20 percent secreted directly from the thyroid 
gland itself. On a weight basis, T3 is about 3 to 5 times more potent as a thyroid hormone 
than T4 and is believed to be the biologically active form of the hormone(48). TSH, 
secreted by thyrotroph cells located in the anterior pituitary gland, regulates thyroid gland 
function and hormone synthesis and release(40).  
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The pituitary secretion of TSH in turn is influenced by the releasing factor, thyrotropin-
releasing hormone (TRH) produced in the hypothalamus . The secretion of both TSH and 
TRH is regulated by negative feedback from thyroid hormone, predominantly T3, from 
the circulation and/or T3 that is produced locally from intracellular conversion of T4 to T3. 
When circulating thyroid hormone levels are elevated, both the synthesis and secretion of 
serum TSH are blunted(49). In contrast, when circulating levels of T4 and T3 are low, 
serum TSH levels are increased in a compensatory fashion. The geometric mean level of 
serum TSH in normal individuals is approximately 1.5 µU/ml as recently reported in the 
NHANES III study(50). When hypothalamic pituitary function is intact, serum TSH 
levels are markedly suppressed (to <0.05 µU/ml) in patients with hyperthyroidism and 
elevated circulatory levels of serum thyroxine, while a marked increase in TSH (>5 
µU/ml) occurs in patients with hypothyroidism and low blood levels of serum T4. The 
mechanism through which TSH binds to and activates the thyroid gland is well 
understood. TSH binds to a specific membrane receptor located on the surface of the 
thyroid epithelial cell and activates the cell signaling mechanisms through the enzyme 
adenylate cyclase located in the plasma membrane(51). Activation of adenylate cyclase 
increases intracellular cyclic adenosine monophosphate (cAMP) levels, which in turn 
stimulate additional intracellular signaling events that lead to thyroid hormone formation 
and secretion.T4 and T3 circulate bound primarily to carrier proteins. T4 binds strongly to 
thyroxine binding globulin (TBG, ~ 75 percent) and weakly to thyroxine binding 
prealbumin (TBPA, transthyretin, ~ 20 percent) and albumin (~5 percent). T3 binds 
tightly to TBG and weakly to albumin, with little binding to TBPA. The geometric mean 
for serum T4 in normal individuals is approximately 8 µg/dl, while the mean serum 
T3 level is approximately 130 ng/dl. Under normal protein binding conditions, all but 
0.03 percent of serum T4 and 0.3 percent of serum T3 is protein bound. Only a small 
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amount of unbound (or free) T4 (approximately 2 ng/dl) and T3 (approximately 0.3 ng/dl) 
circulates in a free state, and it is this free concentration that is considered responsible for 
the biological effects of the thyroid hormones(52).  
There are physiologic situations associated with a change in the serum concentration of 
these thyroid-binding proteins—such as pregnancy, non-thyroidal illness, or ingestion of 
drugs—that affect the level and/or affinity of these binding proteins(53). Under these 
circumstances, the serum concentrations of total T4 and total T3 change in parallel to the 
changes that occur in the thyroid hormone binding proteins, but the serum concentrations 
of free T4 and free T3 remain normal and the individual remains euthyroid(54). In 
contrast, the serum concentration of free T4 and free T3 are raised in hyperthyroidism and 
decreased in hypothyroidism. 
3.3.11 TESTING FOR DIAGNOSIS OF HYPOTHYROIDISM 
The most sensitive test in an ambulatory population at risk for thyroid dysfunction is the 
serum TSH. Serum TSH assays today have sufficient sensitivity and specificity to 
identify individuals with all forms of thyroid dysfunction in the general population(55). 
However, among individuals with serious, acute illness, the serum TSH is less specific 
for thyroid disease because a serious illness alone can depress TSH. TSH screening of the 
neonatal population to detect congenital hypothyroidism before it is clinically evident is 
mandated throughout the United States and in many other countries. Serum TSH 
measurements may yield misleading results for individuals with changing levels of 
thyroid hormones. For example, a serum TSH level may remain high for weeks in 
hypothyroid patients treated with T4. Similarly, serum TSH levels may remain low for 
weeks after the serum T4 level falls to normal in patients treated for hyperthyroidism. 
 
28 
 
Diagnosis of Hypothyroidism: 
Hypothyroidism is a hypometabolic state that results from a deficiency in T4 and T3. Its 
major clinical manifestations are fatigue, lethargy, cold intolerance, slowed speech and 
intellectual function, slowed reflexes, hair loss, dry skin, weight gain, and constipation. It 
is more prevalent in women than men. The most common cause of hypothyroidism is 
disease of the thyroid itself, primary hypothyroidism. The most common cause of 
primary hypothyroidism is chronic autoimmune thyroiditis (Hashimoto's disease), in 
which the thyroid is destroyed by antibodies or lymphocytes that attack the gland. Other 
causes are radioactive iodine and surgical therapy for hyperthyroidism or thyroid cancer, 
thyroid inflammatory disease, iodine deficiency, and several drugs that interfere with the 
synthesis or availability of thyroid hormone. Hypothyroidism may also occur rarely (<1 
percent of cases) as a result of deficiency of TRH or impaired TSH secretion due to 
hypothalamic or pituitary disease, respectively. This is known as secondary or central 
hypothyroidism because of the negative feedback relationship between serum T4 and 
T3 levels and TSH secretion. People with primary hypothyroidism have high serum TSH 
levels. If an individual has a high serum TSH value, serum free T4 should be measured. 
The concomitant finding of a high serum TSH concentration and a low free T4 level 
confirms the diagnosis of primary hypothyroidism. People with a high serum TSH 
concentration and a normal or low-normal serum free T4 level have, by definition, 
subclinical hypothyroidism. The diagnosis of secondary hypothyroidism is based on the 
findings of a low serum free T4 level and a serum TSH level that is normal or low. People 
with secondary hypothyroidism are unlikely to be detected by a screening program based 
on measurements of serum TSH, but the condition is much less common than primary 
hypothyroidism. 
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3.3.12 CONVENTIONAL TREATMENT FOR HYPOTHYROIDISM 
Historical perspective 
By the end of the 19th century, myxedema had been attributed to diminished thyroid 
function and a cretinism-like condition (also described as cachexia strumipriva) had been 
observed following thyroidectomy in animals and humans(56). Moreover, 
xenotransplantation of animal thyroid gland had been shown to improve symptoms in 
women suffering from myxedema temporarily. In 1891, Murray described the first 
regime of thyroid hormone replacement, subcutaneously injecting extract of sheep 
thyroid into a patient with hypothyroidism(2). It was soon shown that oral administration 
of thyroid extract was as effective. In 1914, Kendall purified thyroxine crystals, which 
became commercially available(3). Harrington identified the structure of thyroxine in 
1926 and synthetic thyroxine was available for clinical use by the 1930s. However, it 
took many more years before thyroxine became preferable to desiccated thyroid extract 
as the treatment of choice for hypothyroidism(4). In 1952, Gross and Pitts-River 
identified the more potent liothyronine. 
Dosage of levothyroxine 
Levothyroxine is the treatment of choice for hypothyroidism. It has a 7 day half-life, 
allowing daily dosing. A randomized controlled trial has shown that, in patients with no 
significant comorbidities, initiation of levothyroxine at a full dose based on body weight 
(1.6 μg/kg/day) is safe, effective, and requires fewer resources than using a more 
traditional approach of starting with a small dose and gradually titrating upward(36). The 
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exceptions to this are the elderly and patients with known ischemic heart disease (see the 
“Levothyroxine replacement in special circumstances” section of this review). 
 Timing of levothyroxine 
Conventionally, hypothyroid patients are advised to take levothyroxine on an empty 
stomach half an hour before breakfast to prevent impairment of absorption by food. 
Several recent studies have looked at whether a bedtime dosage of levothyroxine is 
preferable(57). A small nonrandomized study involving eleven hypothyroid patients on a 
stable dose of morning levothyroxine found a decrease in mean TSH and an increase in 
free thyroid hormone levels when the timing of levothyroxine dosage was changed to 
bedtime(58). The same investigators, in a subsequent randomized double-blind crossover 
trial of 105 consecutive patients, have reaffirmed that biochemical control was best 
achieved by night-time dosing. Taking levothyroxine at bedtime resulted in a decrease in 
mean TSH of 1.25 mIU/L (95% confidence interval [CI] 0.60–1.89), and an increase in 
free T4 of 0.07 ng/dL (95% CI 0.02–0.13) and total T3 of 6.5 ng/dL (95% CI 0.9–
12.1).[34]However, there were no improvements in quality of life scores, blood pressure, 
or lipid profile. A retrospective study of 15 elderly patients in a nursing home showed a 
no significant decrease in mean TSH of 0.29 mIU/L when the time of administration of 
levothyroxine was changed from early morning to midnight(59). In contrast, a 
randomized crossover trial in the US compared taking levothyroxine in the fasting state, 
with breakfast, or at bedtime in 65 patients with primary hypothyroidism and thyroid 
cancer, and found that TSH levels were significantly lower and less variable when 
levothyroxine was taken in the fasting state than at other times(60). Furthermore, Rajput 
et al randomized 77 patients with newly diagnosed autoimmune hypothyroidism to taking 
their levothyroxine half an hour before breakfast or two hours after their evening meal, 
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and found no difference in TSH, lipid profile, clinical symptoms, quality of life scores, or 
the dose required to achieve euthyroidism between the two groups(61). The conflicting 
findings of different studies may reflect heterogeneity in the conditions of patients 
studied (for example, newly diagnosed patients versus patients on a stable dose of 
levothyroxine, and patients with thyroid cancer versus patients with autoimmune 
hypothyroidism) as well as in eating habits in relation to bedtime in the different study 
populations. Nevertheless, these studies suggest that bedtime dosing of levothyroxine 
could be tried as an alternative strategy in those patients who have problems in taking 
morning levothyroxine on an empty stomach(62). 
Monitoring thyroid function during levothyroxine replacement 
When initiating levothyroxine therapy, serum TSH should be measured to monitor for 
adequate replacement. TSH can take up to 4 months to normalize, even when starting on 
a full dose replacement regimen, due to thyrotroph hyperplasia(60). It is recommended 
that the TSH is measured 6–8 weeks after initiation of, or a change in levothyroxine dose. 
Once the patient is on a stable dose of levothyroxine, annual monitoring of TSH is 
recommended, although a retrospective study suggests that the monitoring interval could 
be safely increased to 18 months(10).Common causes of persistently elevated TSH in 
patients on levothyroxine replacement. Causes of persistently elevated thyroid  
stimulating hormone in a patient on levothyroxine  replacement are 
 Inadequate levothyroxine dose 
 Poor compliance with medication (biochemistry usually showing high thyroid-
stimulating hormone with normal free T4) 
 Interaction with concomitant drugs  
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 Taking levothyroxine with food 
 Malabsorption 
 Coexisting celiac disease or autoimmune gastritis 
 Interference with the laboratory assay due to heterophil antibodies 
 Coexisting thyroid hormone resistance (rare) 
It is generally recommended to aim for a TSH in the lower half of the normal range, ie, 
typically <2.5 mIU/L in patients with primary hypothyroidism on levothyroxine 
replacement(12,37). In a small study of 21 patients with primary hypothyroidism, 
titrating the dose of levothyroxine until the TSH was at the lower end of reference range 
or suppressed below the reference range was found to be associated with improved 
wellbeing in some patients.[40]However, this observation was not confirmed by a 
double-blind randomized crossover trial, which has shown that small changes in 
levothyroxine dose to achieve a lower TSH do not result in an improved quality of life 
score(29). Furthermore, in a recent prospective study of 42 patients initiating 
levothyroxine treatment for newly diagnosed primary hypothyroidism, there was no 
difference in lipid profile, body composition, or bone mineral density in patients 
maintained on low TSH (0.4–2.0 mIU/L) as compared with those maintained on higher 
TSH (2–4 mIU/L) for 12 months, although resting energy expenditure was higher in 
patients maintained on the lower TSH target(58). Finally, overtreatment with 
levothyroxine leading to a suppressed TSH of below 0.1 mIU/L has been shown to be 
associated with adverse skeletal health, particularly in the elderly . Taken together, these 
observations suggest that the target TSH level for most nonpregnant patients with 
primary hypothyroidism on levothyroxine replacement should be the population 
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reference range and one should not necessarily increase the dose of levothyroxine in 
asymptomatic people with a TSH in the upper half of the normal range. 
Drug interactions with levothyroxine 
Several medications, supplements, and food can interfere with the absorption and action 
of levothyroxine .Common drugs that can affect levothyroxine absorption include iron, 
calcium, cholestyramine, and aluminum and levothyroxine must be taken at least 4 hours 
apart from these drugs(10). Enzyme inducers, such as phenytoin, carbamazepine, 
phenobarbital, and rifampicin can increase the clearance of levothyroxine, necessitating 
an increased dose(15). Of women starting estrogen hormone replacement treatment, 35% 
were shown to need an increase in levothyroxine dose, thought to be due to increased 
thyroxine-binding globulin(25). It is noteworthy that hypothyroidism itself can lead to 
altered metabolism of medications, such that when rendered euthyroid, patients with 
hypothyroidism may need alterations in the dose of their medications. For example, 
initiation of levothyroxine in a hypothyroid patient may enhance the effect of warfarin, 
which may need dose adjustment(63). 
Substances that interact with levothyroxine  
Drugs and supplement that decrease the effect of Levothyroxine are Iron, Calcium 
carbonate, Cholestramine, Aluminum,Cimetidine, Sucralfate, Iodine, 
Selenium,Magnesium, Zinc, Soya, Fiber, Caffeine, Antacids, Increased levothyroxine 
clearance, Phenytoin, Carbamazepine, Phenobarbital, Rifampicin, Increased 
Levothyroxine binding,Estrogen hormone replacement therapy, Drug affected by 
levothyroxine,Drug effect enhanced by levothyroxine, Warfarin,Amitriptyline, Drug 
effect decreased by levothyroxine, Propranolol.(20,61) 
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3.3.13 COMPLEMENTARY TREATMENT FOR HYPOTHYROIDISM: 
The National Institutes of Health National Center for Complementary and Alternative 
Medicine (NIH NCCAM) defines complementary medicine as being used along with 
standard medical treatments, and alternative medicine as being used in place of standard 
medical treatments. Integrative medicine is a comprehensive approach to care that 
includes a patients’ mind body and spirit; this combines standard medicine with CAM 
practices 
TYPES OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) 
The NIH NCCAM uses five categories to describe the different types of CAM. It would 
be difficult to create a comprehensive list, but some examples are described below: 
MIND-BODY MEDICINES 
These are based on a belief that the mind is able to affect your body. Examples include: 
 Yoga 
 Meditation 
 Hypnosis 
BIOLOGICALLY-BASED PRACTICES 
These include things most often found in nature, and includes dietary supplements and 
herbal products. Examples include: 
 Vitamins 
 Herbs 
 Special diets 
The patients with Hypothyroidism are recommended to practice a special diet that avoids 
foods that contain iodine. In fact, use of iodine either in liquid form or as a supplement is 
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not recommended. It’s also common for patients to be told to take Vitamin D or calcium 
supplementation.  
MANIPULATIVE AND BODY-BASED PRACTICES 
These are based on working with the body and are thought to have underlying benefits 
for the mind as well. Examples include: 
 Massage 
 Chiropraxy 
ENERGY MEDICINE 
Energy medicine invokes the belief that the body has energy fields that can be 
manipulated for healing and wellness. Examples include: 
 Reiki 
 Tai Chi 
WHOLE MEDICAL SYSTEMS 
These systems include beliefs and approaches to healing and wellness that come from all 
of the world and from many cultures[44]. Examples include: 
 Naturopathy 
 Homeopathy 
 Chinese medicine 
 Vodun/Expiritism 
 Ayurvedic medicine 
 
3.3.14 EFFECT YOGA AND PRANAYAMA ON HYPOTHYROIDISM  
Yogic disciplines involving Pranayama claimed to have very good effect on Thyroid 
function , thus creating psychic and somatic equilibrium of the bodily functions. 
36 
 
Pranayama in actuality is regarded as the science of controlled as well as conscious 
expansion of the prana representing the life force. The practice of pranayama helps in 
facilitating the therapeutic potential for several systemic complications. The study 
conducted on Diagnosis and Management of Hypothyroidism states that hypothyroidism 
presents a large epidemiological burden in India(37). As a result of subtle and non 
speciﬁc clinical symptoms and signs, the condition often goes undiagnosed and is not 
adequately treated when it is detected. There is heterogeneity in the diagnostic and 
treatment approaches to hypothyroidism. As a result of the physiological changes in 
thyroid hormones with age and illness, it is important to tailor the diagnosis and 
management of this condition in speciﬁc populations including pregnant women, infants, 
children, geriatric patients, and those with comorbid conditions. Enhanced understanding 
and education of physicians and patients can help to improve the outcomes of treatment 
in hypothyroidism which should be focused on patient-centered care. Policies and 
reforms should be crafted and implemented at the national level to curb public health 
challenges of hypothyroidism. This publication summarizes the recommendations of a 
national advisory board meeting to identify and bridge the gaps in understanding of the 
diagnosis and treatment of hypothyroidism in India. As a complement to clinical 
judgment, these recommendations will foster the diagnosis and management of 
hypothyroidism in the community and clinics for the beneﬁt of the patients.  In the study 
conducted in 2017 stated that hypothyroidism is a commonly prevailing disorder in adult 
Indian population(63). Hypothyroidism may occur as a result of primary gland failure or 
insufficient thyroid gland stimulation by the hypothalamus or pituitary gland. 
Hypothyroidism is a common endocrine disorder resulting from deficiency of thyroid 
hormone or, more rarely, from their impaired activity at tissue level. 
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Hypothyroidism is characterized by a broad clinical spectrum ranging from an overt state 
of myxedema, end-organ effects and multisystem failure to an asymptomatic or 
subclinical condition with normal levels of thyroxine and triiodothyronine and mildly 
elevated levels of serum thyrotropin(1). The prevalence of hypothyroidism in the 
developed world is about 4-5%. In a developing and densely populated country like 
India, communicable diseases are priority health concerns due to their large contribution 
to the national disease burden. 
 The study on The Thyroid registry states that Patients with SCH have a high rate of 
progression to overt hypothyroidism(61). However, the true prevalence of SCH could not 
be determined as T4 values were not a part of the clinical assessment in majority of 
patients (n = 1208); this could be higher in our population. In the study, TSH and T4 
levels were available for only 291 patients at baseline. This highlights the fact that 
common clinical practice is focused only on screening patients for TSH levels and does 
not include T4 estimation. In addition, for patients with TSH level at borderline or <10 
mIU/L, it is recommended that the decision to treat should be based on T4 levels. The 
thyroid hormone profile, levothyroxine dose, and resolution of symptoms, if any, were 
being recorded for subsequent follow-up visits. However, this study brings out an 
important deficit in the clinical practice and management of hypothyroidism in India, 
warranting the need for educating our medical fraternity. Appropriate assessment with 
both T4 and TSH levels and when required, assessment of T3 level and thyroid 
peroxidase antibodies are essential and should be practiced in routine clinical setup. 
Guidelines suggest a diagnosis of hypothyroidism based on TSH and T4 levels. However, 
most of the patients from this registry study were advised treatment with levothyroxine 
based on TSH levels alone, thus highlighting the need for awareness and scientific 
education among clinicians in India. Levothyroxine replacement is the standard of 
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treatment for hypothyroidism and is tailored. The use of standard doses (100, 75, and 25 
mcg) of levothyroxine may point toward empirical management practices. However, this 
needs to be further evaluated. 
In the study it is observed that a significant reduction in total cholesterol (8.99%), LDL 
(9.81%) and triglycerides (7.65%), and significant improvement in HDL cholesterol 
(9.65%)(60). The mean thyroxine medication score was medication was observed in any 
of the subjects at the end of the study. Previously, two studies have looked into the 
efficacy of yoga in hypothyroidism. In a study on 20 hypothyroidism women, 1 month of 
yoga practice showed significant improvement in the quality of life(64), and in another 
study, 6 months of pranayama (yogic breathing) practice improved forced expiratory 
volume in lung function test of women with hypothyroidism (63). These studies are 
suggestive of positive role of yoga practice in hypothyroidism. Similarly, in our pilot 
study we observed the positive effect of yoga practice in hypothyroidism. In earlier 
studies, 12 weeks of yoga intervention in elderly women with diabetes showed significant 
reduction in triglycerides, total cholesterol, LDL and improved HDL(25). In another 
randomized control trial, 6 months of yoga nidra (yogic relaxation method) practice was 
shown to reduce the serum TSH level in females with menstrual abnormalities(10). In our 
study also we found similar results as that of the previous one. The exact mechanism 
behind these finding is not known. One of the possible mechanisms could be increased 
physical activity due to Suryanamaskar and physical postures might have helped in 
reducing triglycerides, total cholesterol, LDL and increased HDL cholesterol(29). The 
pranayama, relaxation practices and meditation are known to reduce stress and modulate 
the hypothalamo-pituitary–adrenal axis(57). Similarly, yoga practice might influence the 
hypothalamo-pituitary–thyroid axis and lead to decrease in serum TSH. This study shows 
the potential role of yoga in the management of hypothyroidism and preventions of 
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cardiac disease due to hypothyroidism(65).Future studies should include the randomized 
controlled design with a larger sample size and other objective variables like 
cardiovascular parameters, psychological variable along with thyroid hormones. Long-
term practice of yoga may help in improving cholesterol level, serum TSH and thyroxine 
requirement in female patients suffering from hypothyroidism. However, further 
randomized controlled studies need to be conducted. The effect of yogic practices was 
significant for hypothyroid patients in improving their quality of life. Prior to the therapy, 
scores on the physical health domains were low,the improved significant after therapy 
indicate that the physical health of hypothyroid patients had been improved. Patients 
reported that theywere more finding the activities of daily living easier, they were more 
energetic, mobile and their work capacity had increased. They also reported less pain and 
discomfort. The results also indicated a positive effect from yoga practice on 
psychological health. Following therapy patients scores had markedly improved from pre 
therapy scores with a post therapy scores. Subject reported feeling more positive and 
expressed higher perceptions of self esteem,nothing that they were happy with their body 
image and appearance. 
 In the domine of social relationships. Patients reported a significant increase in the 
scores, The quality of life scores on social relationship domin before yoga therapy 
compared to post therapy rating.The practice of yoga generally leads to a more efficient 
functioning of the psycho- neuro- endocrine and immune system. This is affected by 
increased physical flexibility and greater awareness of breathing and body posture. A 
continued focus upon body posture and breathing and body posture. A continued focus 
upon body posture andbreathing in yoga serves to emphasize an awareness of the impact 
of changing emotional states upon the body. In turn , Poonam singh stated that such 
awareness serves to promote a more balanced equilibrium between the sympathetic and 
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parasympathetic autonomic nervous system and thus state of health.  Another study 
conducted by Swami G et al on effect of yogic practice on pulmonary function tests of 
hypothyroidism patient  concludes  that yoga has beneficial effect on pulmonary function 
test of hypothyroid, patients use to improve in their respiratory muscle strength and 
increased air entry which increase oxygen concentration at tissue level(54,55).A study 
conducted by Minal S.Pajai et al highlights the importance of Ujjayi as follows: Ujjai is 
sometimes called “the ocean breath”.Ujjayi is the diaphragmatic breath, which first fills 
the lower belly( activating the first and second chakras)and finally moves into the upper 
chest and throat. Inhalation and exhalation are both done through the nose. The “Ocean 
sound” is created by moving the glottis as air passes in and out. As the throat passage is 
narrowed it creates a rushing sound. The length and speed of the mind is also facilitated. 
It has a positive effect on whole mind and body as particularly on nervous system. It 
improves the functioning of all endocrine gland by its soothing effect especially thyroid 
gland. It helps to secrete hormones from thyroid gland in required quantity.The study 
concluded that yoga is valuable in helping the hypothyroidism patient to manage their 
disease related symptoms(66).Yoga may be concluded as supportive or complementary 
therapy in conjuction with medical therapy for the treatment of hypothyroid disorder. In 
the Research study established that the yogic Asana,Pranayama and the kriyas are the 
best and useful as they help not only to strengthen each organ and develop every muscle 
of the body but also regulate the circulation of body blood, purity of lungs, inspire the 
mind and thus develop the harmonious development of human personality(41). 
Pranayama is the science of respiration. The author of Hatha Pradipaka give eight 
varieties of pranayama, one of which is Ujjayi. The chief characteristic of Ujjayi 
pranayama improves the circulation of blood can capable of producing very high pressure 
in the lung and in the thorax(62).Yogic breathing, otherwise referred to as pranayama 
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involves with rhythmic and slower and deeper breathing, inspired by the predominant 
usage of abdominal musculature as well as the diaphragm. The breathing is held 
momentarily with full inspiration, which is within the limits of an individual‘s comfort as 
it allowed a spontaneous exhalation at a slower pace. The respiration if paused again 
within the individual‘s limits of comfort with full exhalation. The incorporation of 
pranayama technique over conventional exercise in particular, appeared to have 
beneficial for the individuals who are susceptible to ischemic heart disease and other 
cardiovascular complications. The practice involving the activity which is gradually 
incremental, aids in accelerating the recovery processes initially after a person who 
suffered with myocardial infarction. Even when the practice of pranayama has been 
popularized only to a limited extend in Asian region, especially in India, there has been a 
significant shift among the western society towards practicing yoga and pranayama over 
the recent year.
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 UPANISHAD’S DEPICTION ON THE PRACTICE OF PRANAYAMA 
There are several reports on ancient scripts that strongly supports the benefits of practice 
of pranayama. 
 
The Chhandogya Upanishad (1:11:5) says 
: 
 
 
 
 
In prana all moveable and immoveable beings merge (during dissolution) and rise out of 
prana (during creation).1Pranayama is the pause in the movement of inhalation and 
exhalation when that is secured. Inhalation and exhalation are methods of inducing 
retention. Retention is the key because it allows a longer period for the assimilation of 
prana, just as it allows more time for the exchange of oxygen and carbon dioxide in the c 
ells. As the breath is also intimately connected with various functions and organs of the 
body as well as the mind, by controlling the breath we also influence all these 
dimensions. A balanced, sequential movement from gross to subtle, from annamayakosha 
to anandamayakosha, is the aim.  
 
 
43 
 
 
 
In the Hatha Yoga Pradipika(1:67) it has been said: 
 
 
 
 
Asanas, various types of kumbhaka (pranayama) and the other various means of 
illumination should all be practiced in the hatha yoga system until success in raja yoga is 
attained. 
 
The Shiva Samhita(3:57) states: 
 
 
 
When one attains the power of holding the breath for three hours, then certainly the 
wonderful state of pratya-hara is reached without fail. 
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It is said in the Kathopanishad(2:3:2): 
 
 
 
This whole world - whatever there is - vibrates having originated from prana.This cosmic 
prana, also called mahaprana, came into being at the time of creation. Thus, in order to 
fully understand prana, one must go back to the beginning of creation.The tranquillizing 
practices of pranayama are designed to relax the body and mind, while simultaneously 
increasing the pranic capacity and conscious awareness. 
 
YOGA 
Yoga means ‘union’ or ‘connection’. In Sanskrit, the word ‘yoga’ is used to signify any 
form of connection. Yoga is both a state of connection and a body of techniques that 
allow us to connect to anything. Conscious connection to something allows us to feel and 
experience that thing, person, or experience. The experience of connection is a state of 
yoga, a joyful and blissful, fulfilling experience.Awareness is the secret of yoga. 
Patanjali’s definition of yoga  
The great sage Patanjali, in the system of Raja Yoga, gave one of the best definitions of 
yoga. He said, ‘Yoga is the blocking (nirodha) of mental modifications (chitta vritti) so 
that the seer (drashta) re-identifies with the (higher) Self. Patanjali’s system has come to 
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be the epitome of Classical Yoga Philosophy and is one of the 6 or 7 major philosophies 
of India. 
Hatha yoga definition  
Hatha yoga includes postures (asana), breathing techniques (pranayama), purification 
techniques (shat karmas) energy regulation techniques (mudra and bandha). The 
definition of yoga in the Hatha Yoga texts is the union of the upward force (prana) and 
the downward force (apana) at the navel center (manipura chakra). Hatha yoga teaches 
us to master the totality of our life force, which is also called prana. By learning how to 
feel and manipulate the life force, we access the source of our being. 
Patanjali gives a wide range of techniques that slowly harmonizes the mind and gradually 
induces more subtle perception. However, the main path of Patanjali is contained within 
eight fundamental stages. The first five are: 
 Yama (social code) 
 Niyama (personal code) 
 Asana (sitting pose) 
 Pranayama (control of prana) 
 Pratyahara (sense withdrawal)  
 Dharana (concentration) 
 Dhyana (meditation) 
 Samadhi (superconsciousness) 
These first five stages are the esoteric/bahiranga (external) practices of yoga. They 
progressively prepare the body-mind for the last stages are the esoteric or antaranga 
(internal) practices of yoga. The first five stages negate consciousness, whilst the last 
three stages expand consciousness. 
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1.10 PRANAYAMA 
Practicing Pranayama helps in controlling the breath. The terminology was coined  from 
the two root words namely ‘prana’ meaning ‗vital energy‘ and ‗ayama’ meaning 
extension/breath‘. The practice of pranayama cannot be considered as a simplified 
breathing exercise; rather it aims at channeling the flow of excess oxygen into the lungs, 
thereby, transporting it to all the systemic organs of the body.In the pranayama practices 
there are four important aspects of breathing which are utilized. These are: 
 Pooraka or inhalation 
 Rechaka or exhalation 
 Antarkunbhaka or internal breath retention 
 Bahirkumbhaka or external breath retention. 
 
As Yoga was globally regarded as The ancient Indian science‘ which comprised of 
practices, which involved specific postures (asanas) and regulated breathing 
(Pranayama). There were reports suggesting different types of pranayama exhibiting 
different autonomic and cardiac responses among healthy humans. Many reports claimed 
that the practice of pranayama aids in eliminating the toxins away from the body and 
helps in maintaining a good health. 
There are different variations/types of pranayama such as 
 AnulomVilom Pranayama 
 Bahya Pranayama 
 Bhastrika Pranayama 
 Bhramari Pranayama 
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 Digra Pranayama 
 Kapalbhati Pranayama 
 NadiSodhana Pranayama 
 Shitali Pranayama 
 Udgit Pranayama 
 Ujjayi Pranayama 
1.11 GHERANDA SAMHITA  
Gheranda Samhita  is a Sanskrit text of Yoga in Hinduism. It is one of the three classic 
texts of hatha yoga . The Gheranda Samhita calls itself a book on ghatastha yoga, which 
literally means "vessel yoga", wherein the body and mind are depicted as vessels that 
carry and serve the soul (atman, purusha). The text teaches a seven limbed. Gheranda 
Samhita is a step by step detailed manual of yoga taught by sage Gheranda to student 
Chanda Unlike other hatha yoga texts, the Gheranda Samhita speaks of a sevenfold Yoga 
and Pranayama is one of the important practice explained in this text 
1.12 UJJAYI  PRANAYAMA – The Psychic Breath 
Ujjayi Prananaya or the psychic breath soothes the mind and induces a meditative 
state.  Ujjayi means to ‘lift up’. In Ujjayi pranayama, the chest is slightly lifted up as if 
the inhalation is done from the throat. Ujjayipranayama is mentioned in the yoga 
text Hatha Yoga Pradeepika and in the Gheranda Samhita. 
Ujjayi involves a deep inhalation from both nostrils with a half closed glottis, so that a 
faint hissing snoring sound is made during the inhalation. Then there is retention of 
breath followed by exhalation. Those suffering from heart ailments and blood pressure 
problems should avoid Kumbhaka or retention of breath. This practice should be learnt 
from a qualified yoga instructor. 
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4.0 MATERIALS AND METHODS 
4.1SUBJECTS 
A total of 120 subjects of both gender with age group ranging between 18 – 55 years 
will participate in the study. 
4.2 DESIGN   
 4.2.1 Type of design: A Randomized Controlled Trial 
4.3 SAMPLE SIZE 
120 healthy volunteers of age group between 18 -55yrs will participate in the study. The 
subjects will be recruited from the Out – patient department of Government Yoga and 
Naturopathy Medical College Hospital, Chennai 
4.4 STUDY CENTRE: Government Yoga and Naturopathy Medical College,Departement 
of Yoga,Arumbakkam, Chennau -106 
4.5 DURATION OF THE STUDY 
Duration of the entire intervention procedure: 
Training period: 12 week 
Intervention period: 12 week 
Frequency of practice: twice per day 
Duration of practice: minimum of 15 min 
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4.6CRITERIA FOR DIAGNOSIS 
4.6.1 Inclusion Criteria: 
 Inclusion criteria 
 Age between 18-55 years 
 Both genders 
 Pre Diagnosed Hypothyroidism pstient  
 Patient with Hypoythyroidism who are interested in involving themselves in 
yogic practice. 
 
4.6.2Exclusion criteria: 
 Nervous system or respiratory ailments, hypertension and diabetes mellitus 
 Cardiovascular disease, renal complications, liver disorders and locomotors 
disabilities 
 Glaucoma , hernia, or ulcers of the stomach or intestine 
 Recent abdominal or spinal surgery 
 Obese female with pregnancy or Lactation and children 
 Any type of Addiction like smoking, alcoholism, tobacco chewing, etc  
4.7  WITHDRAWAL CRITERIA: 
All subjects are free to withdraw from participation in the study at any time, for any reason, 
specified or unspecified, and without prejudice to further yogic practices. Subjects who are 
withdrawn from the study will not be replaced. 
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    4.8 STUDY DESIGN PLAN: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Convenient sampling (n=120) 
Study group (n=60) Control group (n=60) 
Pre assessment 
Standard treatment without ujjayi 
practice for 12 weeks 
Post assessment to assess the 
changes in BMI, thyroid function test 
Pre assessment 
Ujjayi pranayama along with 
standard treatment for 12 weeks 
Post assessment to assess the 
changes in BMI, thyroid function test 
Day 1 
Twice daily 
Day - 90 
Statistical data analysis and results 
        Potential subject will be screened 
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4.9 ASSESSMENTS: 
     Yoga session for 12 weeks under supervision at Government yoga and naturopathy 
medical college and hospital,each session lasting for about 15 minutes twice a day for 6 
days a week. BMI, Thyroid function Test-[Tri-iodothyronine, Thyroxine, Thyroid- 
stimulating hormone] for the Patients will be measured before and after 12 week in control 
group and study group.  
Primary outcome variables: 
(a)Body Mass Index(BMI = Weight/Height in sq.meter) 
(b)Thyroid Function Test – [Tri-iodothyronine T3, Thyroxine T4,Thyroid stimulating 
hormone TSH] 
Description : 
Primary outcome variables: 
(a)The body mass index(BMI) 
Height: Using standard measuring tape, height in meters or centimeters or inches of each 
patient would be measured.Using standard measuring weighing machine 
KRUPS,ESSAE,EEROKA LTD to measure the weight in kilogram or pounds of each 
patient.The boby mass index (BMI) is a value derived from the mass(weight) and height of 
an individual.The BMI is defined as the body mass divided by the square of the body height 
and is universally expressed in units of kg/m2, resulting from mass in kilograms ans height 
in metres. 
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(b) Thyroid Function test: 
Thyroid function tests(TFTs) is a collective term for blood tests used to check the function 
of the thyroid.TFT is requested to patient who are throught to suffer from hyperthyroidism 
(overactive thyroid) or hypothyroidism(underactive thyroid) or to monitor the effectiveness 
of either thyroid –suppression or hormone replacement therapy. It is also requested routinely 
in conditions linked to thyroid disease, such as atrial fibrillation and anxiety disorder.A TFT 
panel typically includes thyroid hormones such as thyroid stimulating 
hormone(TSH),Thyroxine (T4),Triiodothyronine (T3 ) depending on local laboratory policy. 
Thyroid hormones 
Thyroid - stimulating hormone 
Thyroid stimulating hormone ( TSH, thyrotropin) is generally increased in hypothyroidism 
and decreased in hyperthyroidism. Its measurement is more sensitive test for thyroid 
hormone function. TSH is produced in the pituitary gland. The production of TSH is 
controlled by thyrotropin releasing hormone(TRH), Which is produced in hypothalamus. 
TSH levels may be suppressed by excess free T3 or free T4 in the blood.  
 
Total thyroxine 
 Total thyroxine is rarely measured, having been largely superseded by free thyroxine tests. 
Total thyroxine(total T4) is generally elevated in hypothyroidism and decreased in 
hypothyroidism.It is usually slightly elevated in pregnancy secondary to increased levels of 
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thyroid binding globulin(TBG).Total T4 is measured to see the bound and unbound level of 
T4. The total T4 is less useful in cases where there could be protein abnormalities. The total 
T4 is less accurate due to the large amount of T4 that is bound. The total T3 is measured in 
clinical practice since the T3 has decreased amount that is bound as compared to T4. 
Reference range depend upon method of analysis. Results should always be interpreted 
using the range from the laboratory that performed the test. 
Total triiodothyronine 
Total triiodothyronine(Total T3) is rarely measured, having been largely superseded by free 
T3 tests. Total T3 is generally elevated in hyperthyroidism and decreased in 
hypothyroidism. 
4.10 ETHICAL CLEARANCE: 
Ethical Clearance: The study was convened after obtaining approval from the 
Institutional Ethics Committee 
 Informed Consent: 
Subjects who fulfilled inclusion criteria were apprised about the purpose of the study 
and their rights as research subjects. Informed consent form was administered in 
English and  time was given to each patient to go through the information sheet and 
their queries were answered. Their right to withdraw any time from the study and the 
need for willingness to participate voluntarily in the study was explained. The subjects 
who expressed their willingness to participate in the study gave a signed informed. A 
sample information sheet and consent form is enclosed as Annexure 1. 
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4.11 METHODOLOGY: 
Men and women with hypothyroidism of age group between 18 - 55 years will participate in 
the study.The patients will be referred by the In-patient and Out-patient department of Yoga 
& Naturopathy,Government Medical College and Hospital, Arumbakkam, Chennai-106. 
After obtaining informed consent, they will be subjected to general measures like BMI, 
Thyroid Function Test – [ Tri-iodothyronine T3, Thyroxine T4, Thyroid – stimulating 
hormone] and they would be subjected to psychic breath for 15 minutes/ twice a day for 12 
weeks, under the supervision of Department of Yoga and Naturopathy, Government Yoga 
and Naturopathy Medical College, Chennai-106. 
 
4.12 DATA COLLECTION: 
 Step 1: Recruitment of patients. 
 Step 2: Randomization (control group and yoga group) 
 Step 3: Pre data measurement – BMI, Thyroid Function Test –[Tri-iodothyronine T3, 
Thyroxine T4, Thyroid stimulating hormone] 
 Step 4: Ujjayi pranayama 
 Step 5: Post data collection BMI, Thyroid Function Test –[ Tri-iodothyronine T3, 
Thyroxine T4, Thyroid stimulating hormone] 
 Step 6: Data entry and Analysis  
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4.13STATISTICAL ANALYSIS: 
Paired t test and  one way ANOVA followed with post hoc test was performed to find the 
variation of mean using R statistical software. 
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5.0 RESULT: 
Total of 120 hypothyroidism patient was included in the study out of that randomly 60 
patients was chosen using simple random sampling to practice yoga for 90 days along with 
conventional medicine and the other 60 patients was included in the control group only with 
conventional medicine. Two samples in control group were not able to continue the study 
completely due personal reason. Gender wise distribution among the yoga group and control 
group was plotted in figure 1 and 2 respectively. Proportion of females were more in the 
samples, this difference existed largely due to high prevalence of hypothyroidism among 
females. The average age of the participants in yoga group was 40.21%. The average age of 
the participants in control group was 41.16%. 
Figure 10: Gender distribution within study group 
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Figure 11: Gender distribution between control and study group 
 
Results of the pre and post measurements on T3, T4, TSH, Body weight and BMI  among 
Ujjayi pranayama along with standard drug group for a period of 90 days was tabulated in 
Table.1. It shows that Body weight was reduced after practicing Ujjayi pranayama for the 
study period. T3 got raised statistically significant after the yoga intervention where as T4 
doesn’t show’s any statistical significance after the yoga intervention. Even though in yoga 
intervention group T4 doesn’t show statistical significance its mean value raised to a marked 
level from 8.05 to 8.54ng/ml This shows that Ujjayi pranayama is influencing the T4 
secretion.  TSH level reduced significantly after the practice of Ujjayi pranayama for a 
period of 90 days.  
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Table 1: Representation of pre and post variables between groups  
 
 
Pre_Post 
Variables 
Between 
Groups 
Paired Differences 
t Df 
P 
Value Mean 
Std. 
Deviation 
Std. Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
BMI 1.18685 0.60099 0.07759 1.03160 1.34211 15.297 59 0.001 
T3 -.25883 0.51378 0.06633 -.39156 -.12611 -3.902 59 0.001 
T4 -.48317 3.07451 0.39692 -1.27740 .31106 -1.217 59 0.228 
TSH 0.65250 2.17484 0.28077 0.09068 1.21432 2.324 59 0.024 
WEIGHT 2.967 1.551 0.200 2.566 3.367 14.816 59 0.001 
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Table 2. The Descriptive Analysis between groups 
Table: 2 Descriptive Statistics 
CONTROL  Mean N Std. Deviation Std. Error Mean 
BMI PRE 33.0755 60 5.11100 0.65983 
POST 31.8886 60 5.09652 0.65796 
T3 PRE 
POST 
1.0768 
1.3357 
60 
60 
0.53616 
0.45523 
0.06922 
0.05877 
T4 PRE 
POST 
8.0578 
8.5410 
60 
60 
3.15348 
2.46068 
0.40711 
0.31767 
TSH PRE 
POST 
9.8958 
9.2433 
60 
60 
4.27655 
3.39037 
0.55210 
0.43770 
WEIGHT PRE 
POST 
82.33 
79.37 
60 
60 
12.576 
12.425 
1.624 
1.604 
STUDY GROUP  
Mean N Std. Deviation Std. Error Mean 
BMI PRE 
POST 
32.5155 
32.9314 
58 
58 
5.25440 
5.21355 
0.68994 
0.68457 
T3 PRE 
POST 
1.0302 
3.2921 
58 
58 
0.61005 
16.40770 
0.08010 
2.15444 
T4 PRE 
POST 
7.8640 
7.9013 
58 
58 
2.62319 
3.10327 
0.34444 
0.40748 
TSH         PRE 
POST 
10.9926 
11.0278 
58 
58 
6.13119 
4.37456 
0.80506 
0.57441 
WEIGHT PRE 
POST 
81.48 
82.53 
58 
58 
12.998 
12.754 
1.707 
1.675 
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Table 3: Equality of variances using independent T test. 
Table: 3 INDEPENDENT T TEST 
  Levene's Test for 
Equality of 
Variances t-test for Equality of Means 
  
F Sig. T Df P value 
Mean 
Differenc
e 
Std. Error 
Differenc
e 
95% Confidence 
Interval of the 
Difference 
  Lower Upper 
BMI Equal variances 
assumed 
0.823 0.366 -0.530 116 0.597 -.56998 1.07568 -2.70051 1.56054 
Equal variances 
not assumed 
  
-0.528 
107.83
4 
0.599 -.56998 1.08014 -2.71105 1.57109 
T3 Equal variances 
assumed 
Equal variances 
not assumed 
3.632 0.059 
-0.923 
-0.908 
116 
57.085 
0.358 
0.368 
-1.95640 
-1.95640 
2.11875 
2.15524 
-6.15286 
-6.27205 
2.24006 
2.35925 
T4 Equal variances 
assumed 
Equal variances 
not assumed 
2.917 0.090 
1.243 
1.238 
116 
108.59
0 
0.216 
0.218 
0.63974 
0.63974 
0.51467 
0.51668 
-.37962 
-.38434 
1.65910 
1.66382 
TSH Equal variances 
assumed 
Equal variances 
not assumed 
4.764 0.031 
-2.563 
-2.552 
116 
106.74
8 
0.012 
0.012 
-1.83443 
-1.83443 
0.71562 
0.71882 
-3.25179 
-3.25944 
-.41706 
-.40941 
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There was no statistical significant difference between the body mass index of interventional 
group and control group but the mean value was less in interventional group than control 
group. It shows that practicing ujjayi pranayama additionally leads to reduce body weight. 
The measurement of T3 was statistically significant between interventional group and 
control group whereas T4 was statistically insignificant. There was a marked reduction of 
TSH in interventional group and statistically significant with control group.  
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6.0 DISCUSSION: 
  
The result of this study revealed that practice of Ujjayi Pranayama decreases the Body mass 
index and The Thyroid Function Test in the interventional group significantly in comparison 
to that of the control group. There are many interventions to reduce severity of disease by 
standard conventional treatment which is associated with multiple side effects and the 
present study deals with non pharmacological mode of treatment. In this study, there is a 
significant difference (p within the Study group) in the Body Mass Index , Thyroid 
Stimulating Hormone(TSH), Triiodothyronine (T3 )  at the end of the 90 days in comparison 
to their baseline data. However, no significant differences in Thyroxine (T4) within this 
intervention group following the intervention. Overall, the practice of Ujjayi pranayama for 
90 days among hypothyroid individuals has resulted in the reduction of the Body Mass 
Index , Thyroid Stimulating Hormone(TSH), Triiodothyronine (T3 ) and no significant 
differences in Thyroxine (T4) ,although Ujjayi pranayama improved the quality of living 
and confidence of the participants. The larger sample size is needed to gain better results. 
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7.0 CONCLUSION: 
This study showed that 90 days of Ujjayi Pranayama reduced Body mass index and Thyroid 
Stimulating Hormone(TSH), Triiodothyronine (T3) and no significant differences in 
Thyroxine (T4)  hypothyroid patients. This revealed that yoga practice has significant role in 
improvement in the weight reduction. Further research need in this field with a larger 
sample size and duration is warranted to reveal accurate changes in this field. 
LIMITATIONS: 
 The current study was a pilot study comprising only of minimal number of subjects. 
 The outcome variable used in the study, cannot be inferred, or taken as an overall 
mean, since the age and gender related factors could vary. 
RECOMMENDATIONS: 
The same study can be conducted on a larger population with suitable study design and 
some objective kind of outcome variables could be included to validate the current result 
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8.0 SUMMARY: 
The intended research work aims to evaluate the effect of 12 week Ujjayi pranayama on 
Hypothyroidism in adults and to compare the changes in BMI and Thyroid Function Test 
[Tri- iodothyronine T3,Thyroxine T4, Thyroid-stimulating hormone] before and after 
Psychic breathing technique .Many studies reported that the practice of yoga, especially 
pranayama‘ influences BMI. The current study was conducted to determine the effect of 
practicing Ujjayi Pranayama on Hypothyroidism in Adults, followed by monitoring BMI 
and Thyroid Function Test.The current research work employed A Randomized Controlled 
Trail.In this study Potential subject will be screened and eligible patients will be recruited 
for the study.A minimum of 60 participants in Study group and minimum of 60 participants 
in Control group belonging within the age group of 18-55 participate in the study. After 
obtaining informed consent both the group  will be subjected to general measures like BMI, 
Thyroid Function Test before and after the study. The study Group will be subjected to 
Ujjayi Pranayama for 15 minutes twice a day for 6 days a week for 12  weeks. Results of the 
pre and post measurements on T3, T4, TSH, Body weight and BMI  among Ujjai pranayama 
along with standard drug group for a period of 90 days was tabulated in Table.1. It shows 
that Body weight was reduced after practicing ujjai pranayama for the study period. T3 got 
raised statistically significant after the yoga intervention where as T4 doesn’t show’s any 
statistical significance after the yoga intervention. Even though in yoga intervention group 
T4 doesn’t show statistical significance its mean value raised to a marked level from 8.05 to 
8.54 mg/dl .This shows that ujjai pranayama is influencing the T4 secretion.  TSH level 
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reduced significantly after the practice of ujjai pranayama for a period of 90 days. This study 
showed that 90 days of Ujjayi Pranayama reduced Body mass index and Thyroid 
Stimulating Hormone(TSH), Triiodothyronine (T3 ) and no significant differences in 
Thyroxine (T4)  hypothyroid patients. This revealed that yoga practice has significant role in 
improvement in the weight reduction. Further research need in this field with a larger 
sample size and duration is warranted to reveal accurate changes in this field. 
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10.0 ANNEXURE 1 
 
INFORMED CONSENT FORM 
 
Title of the study: “EFFICACY OF UJJAYI PRANAYAMA ON 
HYPOTHYROIDISM IN ADULTS – A RANDOMIZED CONTROLLED 
TRIAL” 
Name of the Participant: 
 
Name of the Principal Investigator: Dr. S.Vinudha 
 
Name of the Institution: Government Yoga and Naturopathy Medical College, 
Arumbakkam, Chennai – 600 106. 
Documentation of the informed consent 
I _____________________________ have read the information in this form (or it has 
been read to me). I was free to ask any questions and they have been answered. I am 
over 18 years of age and, exercising my free power of choice, hereby give my consent 
to be included as a participant in “Efficacy of Ujjayi pranayama on Hypothyroidism in 
Adults –A Randomized Control Trial ” 
1. I have read and understood this consent form and the information provided to me. 
2. I have had the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained about my rights and responsibilities by the investigator.
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5. I have been informed the investigator of all the treatments I am taking or have taken 
in the past ________ months including any native (alternative) treatment. 
6. I have been advised about the risks associated with my participation in this study. 
7. I agree to cooperate with the investigator and I will inform him/her immediately if I 
suffer unusual symptoms. 
8. I have not participated in any research study within the past ________month(s). 
9. I am aware of the fact that I can opt out of the study at any time without having to 
give any reason and this will not affect my future treatment in this hospital. 
10. I am also aware that the investigator may terminate my participation in the study at 
any time, for any reason, without my consent. 
11. I hereby give permission to the investigators to release the information obtained 
from me as result of participation in this study to the sponsors, regulatory authorities, 
Govt. agencies, and IEC. I understand that they are publicly presented. 
12. I have understood that my identity will be kept confidential if my data are publicly 
presented. 
13. I have had my questions answered to my satisfaction. 
14. I have decided to be in the research study.
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I am aware that if I have any question during this study, I should contact the investigator. 
By signing this consent form I attest that the information given in this document has been 
clearly explained to me and understood by me, I will be given a copy of this consent 
document. 
 
For adult participants: 
 
Name and signature / thumb impression of the participant (or legal representative if 
participant incompetent) 
 
Name_________________________ Signature_________________ 
 
 
Date________________ 
 
 
Name and Signature of impartial witness (required for illiterate patients): 
 
Name _________________________ Signature_________________ 
 
Date _________________ 
 
 
